权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Steroid As Cytoprotectants against Oxidative Toxicity

类固醇作为抗氧化毒性的细胞保护剂

基本信息

批准号：
7214886
负责人：
QIN M CHEN
金额：
$ 35.79万
依托单位：
UNIVERSITY OF ARIZONA
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-04-01 至 2010-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7214886
关键词：
Abbreviations Acids Address Adrenal Cortex Hormones Adrenal Glands Agonist Aldosterone Apoptosis Apoptotic BCL2 gene Benzopyrenes Bile Acids Binding Biological Biological Assay Blood Circulation Cardiac Cardiac Myocytes Cardiomyopathies Cardiotoxicity Cardiovascular Diseases Cell Nucleus Cell Survival Cell membrane Cells Cessation of life Cholesterol Chronic Clinic Conditioned Culture Media Corticosterone Cortisone Cytoprotection Cytoprotective Agent Cytosol Daily Data Dexamethasone Diffuse Dilated Cardiomyopathy Doxorubicin Electrophoretic Mobility Shift Assay Elevation Estrogens Functional disorder Future Gene Proteins Genes Genetic Transcription Genomics Glucocorticoid Receptor Glucocorticoids Grant Heart Heart failure Histone Deacetylase Human Hydrocortisone Hyperactive behavior Immune response Immunoprecipitation In Vitro Induction of Apoptosis Life Link Memory impairment Mental disorders Mifepristone Mineralocorticoid Receptor Neurosecretory Systems Nuclear Receptors Numbers Organ Personal Satisfaction Pharmaceutical Preparations Phosphotransferases Physiological reperfusion Pituitary-Adrenal System Progesterone Protein Biosynthesis Protein Overexpression Proteins Proteomics Rattus Receptor Cell Reperfusion Therapy Reporter Genes Reporting Retinoids Rodent Role Screening procedure Serum Steroids Stress System Testing Testosterone Thyroxine Toxic effect Toxin Transcriptional Activation Transgenic Mice Tretinoin Xenobiotics chemotherapy comparative histone acetyltransferase in vivo interest neoplastic novel pressure prevent promoter receptor research study response transcription factor transcriptomics

项目摘要

DESCRIPTION (provided by applicant): Stress is known to cause an increase in the synthesis of corticosteroids by the adrenal glands. Although corticosteroids have been shown to contribute to the pathophysiology of suppressed Immune response and a number of psychiatric disorders, the effect of CT on the heart remains unclear. Doxorubicin (Dox) is an anti-neoplastic drug that can produce chronic cardiac toxicity which is manifested as dilated cardiomyopathy. An important feature of this form of cardiomyopathy is the apoptosis of cardiomyocytes. Our preliminary studies found that corticosterone (CT) pretreatment prevented Dox from inducing apoptosis of cardiomyocytes. The glucocorticoid receptor antagonist mifepristone prevented CT from inducing a cell survival response. Several forms of g!ucocorticoids, aldosterone, progesterone and retinoic acid but not estrogen, testosterone or L-thyroxin can inhibit apoptosis of cardiomyocytes. Analyses of ERK, Akt and SGK-1 activities or bcl-2 expression indicated that CT neither activated the known survival kinases nor elevated the expression of the anti-apoptotic gene bcl- 2. The conditioned medium of CT-treated cardiomyocytes shows partially cytoprotective effective. The TranSignal array approach found that CT treatment could potentially activate 21 transcription factors. We hypothesize that activation of the glucocorticoid receptor initiates transcriptional activation of survival genes in cardiomyocytes in vitro and in vivo. Specific aims of this grant include: 1) To test if CT binding causes its receptor to interact with and to activate multiple transcription factors in cardiomyocytes; 2) To test that the activation of cell survival genes contributes to CT-induced cytoprotection; and 3) To demonstrate that CT protects the heart from cardiomyopathy induced by Dox in vivo via inducing the transcription of cell survival genes. This project will combine our expertise in genomics, transcriptomics and proteomics to systematically study the linkage between the glucocorticoid receptor and cell survival mechanisms. Given the fact that stress is unavoidable in our daily life, this project will provide novel information to advance our understanding in the biological effect of corticosteroids on the heart. More importantly, since apoptosis has been shown to contribute to heart failure induced by the chemotherapy agent Dox as well as by many forms of cardiovascular disease, our finding and proposed mechanistic study will provide a hope for novel therapy against heart failure in the future.

描述（由申请人提供）：已知应激会导致肾上腺皮质类固醇合成增加。虽然皮质类固醇激素已被证明有助于抑制免疫反应和一些精神疾病的病理生理学，但CT对心脏的影响仍不清楚。多柔比星（Dox）是一种抗肿瘤药物，可产生慢性心脏毒性，表现为扩张型心肌病。这种形式的心肌病的一个重要特征是心肌细胞的凋亡。我们的初步研究发现，皮质酮（CT）预处理可阻止Dox诱导的心肌细胞凋亡。糖皮质激素受体拮抗剂米非司酮阻止CT诱导细胞存活反应。G的几种形式！糖皮质激素、醛固酮、孕酮和维甲酸可抑制心肌细胞凋亡，而雌激素、睾酮和L-甲状腺素则无此作用。ERK、Akt和SGK-1活性或bcl-2表达的分析表明，CT既不激活已知的存活激酶，也不升高抗凋亡基因bcl- 2的表达。CT处理的心肌细胞的条件培养基显示部分细胞保护作用。TranSignal阵列方法发现CT治疗可能激活21种转录因子。我们假设糖皮质激素受体的激活启动了存活基因在体外和体内心肌细胞中的转录激活。该基金的具体目的包括：1）测试CT结合是否导致其受体与心肌细胞中的多种转录因子相互作用并激活它们; 2）测试细胞存活基因的激活有助于CT诱导的细胞保护;以及3）证明CT通过诱导细胞存活基因的转录来保护心脏免受体内Dox诱导的心肌病。该项目将联合收割机结合我们在基因组学、转录组学和蛋白质组学方面的专业知识，系统地研究糖皮质激素受体与细胞存活机制之间的联系。鉴于压力在我们的日常生活中是不可避免的，这个项目将提供新的信息，以促进我们对皮质类固醇对心脏的生物学效应的理解。更重要的是，由于细胞凋亡已被证明有助于由化疗药物Dox以及许多形式的心血管疾病引起的心力衰竭，我们的发现和提出的机制研究将为未来治疗心力衰竭的新疗法提供希望。